T2 Biosystems Announces Second Largest Sepsis-Driven Instrument Sale In Company History; The Initial Order Includes Seven T2DX Instruments, Valued At More Than $450,000, With The Potential For Nine Additional Instruments To Be Sold And Deployed
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the second largest sale of sepsis-driven T2Dx® Instruments in